Transdermal system (tds) that contain inhibitors of phosphodiesterase lV
The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (-) rolipram or (R)-(-)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone.
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a transdermal system that is characterized by a content in a phosphodiesterase IV inhibitor, especially (-) rolipram or (R)-(-)-5-(4-methoxyphenyl-3-propoxy)-5-methyl-2-oxazolidinone. |
---|